Viewing Study NCT06635057


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2025-12-25 @ 4:19 PM
Study NCT ID: NCT06635057
Status: RECRUITING
Last Update Posted: 2025-11-20
First Post: 2024-10-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module